Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer’s New Benchmark For New Era: 8% Annual Growth Is Sustainable

Executive Summary

The pharmaceutical industry is entering a period where average annual growth rates are likely to hover at about 8%, Pfizer CEO Hank McKinnell predicted during a Nov. 30 analyst meeting in Groton, Conn

You may also be interested in...



Marginal Profitability Of Mature Products Not What It Used To Be – Pfizer CEO

Unlike in the past, continued marketing expenditure is necessary to sustain growth for relatively mature products, Pfizer CEO Hank McKinnell said June 13

Marginal Profitability Of Mature Products Not What It Used To Be – Pfizer CEO

Unlike in the past, continued marketing expenditure is necessary to sustain growth for relatively mature products, Pfizer CEO Hank McKinnell said June 13

Personalized Medicine Will Not Destroy Blockbuster Model – Pfizer Exec

The move to personalized medicine will not put an end to the pharmaceutical blockbuster model, Pfizer Senior VP-Science & Technology Peter Corr said May 16

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS045073

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel